Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis
- 11 January 2011
- journal article
- case report
- Published by Wiley in Acta Paediatrica
- Vol. 100 (7) , e36-e39
Abstract
Aim: There is currently no well‐accepted therapy for central nervous system Langerhans cell histiocytosis (CNS‐LCH), a neuroinflammatory disease clinically characterized by often progressive, neurological symptoms including ataxia, dysarthria, dysphagia, hypertonicity, intellectual impairment and behavioural abnormalities. We applied immunomodulative/anti‐inflammatory treatment on a patient with progressive CNS‐LCH disease.Method: Intravenous immunoglobulin (IVIG) was administered monthly for 15 years to a patient with severe, image‐verified neurodegenerative CNS‐LCH.Results: During the IVIG treatment, the neurological deterioration initially appeared to be haltered, but over time there was still some deterioration.Conclusions: IVIG may be beneficial in partly haltering CNS‐LCH neurodegeneration, but further studies are needed.Keywords
This publication has 15 references indexed in Scilit:
- Intravenous Immunoglobulin a Natural Regulator of Immunity and InflammationTransplantation, 2009
- Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensificationBlood, 2008
- Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitisBlood, 2008
- Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapyPediatric Blood & Cancer, 2007
- Risk factors for diabetes insipidus in langerhans cell histiocytosisPediatric Blood & Cancer, 2005
- Long‐term follow‐up of Langerhans cell histiocytosis: 39 years’ experience at a single centreActa Paediatrica, 2005
- Neuropathology of CNS disease in Langerhans cell histiocytosisBrain, 2005
- Histiocyte disordersCritical Reviews in Oncology/Hematology, 2004
- Cognitive Outcome of Long-Term Survivors of Multisystem Langerhans Cell Histiocytosis: A Single-Institution, Cross-Sectional StudyJournal of Clinical Oncology, 2003
- Down‐Regulation of Lymphokine Synthesis by Intravenous Gammaglobulin is Dependent Upon Accessory CellsScandinavian Journal of Immunology, 1998